{Reference Type}: Journal Article
{Title}: Role of pyroptosis in spinal cord injury and its therapeutic implications.
{Author}: Al Mamun A;Wu Y;Monalisa I;Jia C;Zhou K;Munir F;Xiao J;
{Journal}: J Adv Res
{Volume}: 28
{Issue}: 0
{Year}: Feb 2021
{Factor}: 12.822
{DOI}: 10.1016/j.jare.2020.08.004
{Abstract}: <B>BACKGROUND: </B>Currently, spinal cord injury (SCI) is a pathological incident that triggers several neuropathological conditions, leading to the initiation of neuronal damage with several pro-inflammatory mediators' release. However, pyroptosis is recognized as a new programmed cell death mechanism regulated by the stimulation of caspase-1 and/or caspase-11/-4/-5 signaling pathways with a series of inflammatory responses.<BR><B>OBJECTIVE: </B>Our current review concisely summarizes the potential role of pyroptosis-regulated programmed cell death in SCI, according to several molecular and pathophysiological mechanisms. This review also highlights the targeting of pyroptosis signaling pathways and inflammasome components and its therapeutic implications for the treatment of SCI.<BR><B>UNASSIGNED: </B>Multiple pieces of evidence have illustrated that pyroptosis plays significant roles in cell swelling, plasma membrane lysis, chromatin fragmentation and intracellular pro-inflammatory factors including IL-18 and IL-1β release. In addition, pyroptosis is directly mediated by the recently discovered family of pore-forming protein known as GSDMD. Current investigations have documented that pyroptosis-regulated cell death plays a critical role in the pathogenesis of multiple neurological disorders as well as SCI. Our narrative article suggests that inhibiting the pyroptosis-regulated cell death and inflammasome components could be a promising therapeutic approach for the treatment of SCI in the near future.